PRESS RELEASE published on 11/12/2024 at 08:30, 9 days 1 hour ago Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an sur 5 ans
BRIEF published on 11/07/2024 at 18:35, 13 days 15 hours ago Subsidiary of MammoRisk by Predilife for €202 million MammoRisk Breast Cancer International Development Subsidiary Valorization
BRIEF published on 11/07/2024 at 18:35, 13 days 15 hours ago Filialisation de MammoRisk par Predilife pour 202 M€ Développement International Valorisation MammoRisk Cancer Du Sein Filialisation
PRESS RELEASE published on 11/07/2024 at 18:30, 13 days 15 hours ago Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M EUR Predilife annonce la réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M€ pour favoriser son développement international. Création de valeur et partenariats en vue Développement International Valorisation PREDILIFE MammoRisk Apport Partiel D'actif
BRIEF published on 10/30/2024 at 19:05, 21 days 14 hours ago Predilife publishes its 2024 half-yearly financial report Artificial Intelligence Financial Report Euronext Growth PREDILIFE Medical Prediction
BRIEF published on 10/30/2024 at 19:05, 21 days 14 hours ago Predilife publie son rapport financier semestriel 2024 Euronext Growth Rapport Financier Intelligence Artificielle PREDILIFE Prédiction Médicale
PRESS RELEASE published on 10/30/2024 at 19:00, 21 days 14 hours ago Predilife met à disposition son rapport financier semestriel 2024 Predilife met à disposition son rapport financier semestriel 2024, spécialiste des solutions de prédiction de pathologies pour une médecine personnalisée Rapport Financier Médecine Personnalisée PREDILIFE Pathologies Prédiction
BRIEF published on 10/28/2024 at 08:35, 24 days 1 hour ago PREDILIFE Half-Yearly Results and Outlook for 2024 Financial Results Strategic Partnerships Growth 2024 PREDILIFE MammoRisk®
BRIEF published on 10/28/2024 at 08:35, 24 days 1 hour ago Résultats Semestriels et Perspectives de PREDILIFE pour 2024 Résultats Financiers Partenariats Stratégiques Croissance 2024 PREDILIFE MammoRisk®
PRESS RELEASE published on 10/28/2024 at 08:30, 24 days 1 hour ago Résultats semestriels 2024 - Perspectives de croissance 2024 Annonce des résultats semestriels 2024 et perspectives de croissance pour PREDILIFE, spécialiste des solutions de prédiction de risques de pathologies. Des partenariats stratégiques et une croissance attendue Croissance Résultats Semestriels Partenariats Stratégiques PREDILIFE Bilans Prédictifs
Published on 11/21/2024 at 09:00, 57 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 22 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 32 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 57 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 57 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 09:41, 15 minutes ago Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 08:59, 57 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 57 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 41 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 06:58, 2 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 59 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 49 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
